Importantly, SFB potentiation by glycolysis blockade was not limited to liver-derived cells, but also extended to melanoma cells and other cell types, and is likely to be independent from the tumor suppressor p53 (Supplementary Fig. S3). This evidence concerns the gene TP53 and melanoma.